Konstantin Poukalov
Board Member
LianBio (LIANY)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Konstantin Poukalov
Konstantin Poukalov is recorded as Board Member at LianBio (LIANY). The company reported in an 8-K filed December 13, 2024 that Konstantin Poukalov resigned as Director, effective December 12, 2024.
“On December 12, 2024, Michael Altman and Konstantin Poukalov each resigned from the Board of Directors (the "Board") of Lyra Therapeutics, Inc., effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Organization not stated
Board Member
Proxy statement
2020-01-01–2024-12-12
-
Organization not stated
Board Member
Proxy statement
2020-01-01–2024-12-12
Company network
Recorded roles and call appearances connecting this person to public companies.
Company
Board Member
2020-01-01–2024-12-12
Leadership on record at LianBio
Other people whose current roles at this company are on record from its filings.
- Adam Stone CEO, Board Member
- Ehong Gu CFO
- Neil Kumar Board Member
- Susan Silbermann Board Member
- Tassos Gianakakos Board Member
- Wei Wei Chen Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
Executive change Resigned: Director